C. Avendaño Solá-rekin lankidetzan egindako argitalpenak (6)

2024

  1. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

    Bone Marrow Transplantation

2023

  1. Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern

    Journal of medical virology, Vol. 95, Núm. 3, pp. e28679

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  2. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

    Trials, Vol. 22, Núm. 1

2020

  1. A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 9

2018

  1. Conocimiento sobre biosimilares en Atención Primaria: un estudio de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

    Semergen: revista española de medicina de familia, Núm. 6, pp. 380-388